Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis

Hepatology Research

Volumn 46, Issue 3, 2016, Pages E165-E173

  Fan, Yu ^a   Wei, Feifei ^a   Zhou, Yongjing ^a   Zhang, Heng ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Endothelial function; Flow mediated dilation; Meta analysis; Nitrate induced dilatation; Non alcoholic fatty liver disease

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL FUNCTIONS; BLOOD VESSEL PARAMETERS; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL FUNCTION; FLOW MEDIATED DILATION; HIGH RISK PATIENT; HUMAN; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTEMATIC REVIEW;

EID: 84940191898     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12554     Document Type: Article

References (35)

1. Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM 2010; 103: 71-83.
2. Ampuero J, Gallego-Duran R, Romero-Gomez M. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis. Rev Esp Enferm Dig 2015; 107: 10-6.
3. Cheung CL, Lam KS, Wong IC, Cheung BM. Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA. BMC Med 2014; 12: 154.
4. Dunn W, Xu R, Wingard DL etal. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263-71.
5. Ruggiero D, Paolillo S, Ratta GD etal. Endothelial function as a marker of pre-clinical atherosclerosis: assessment techniques and clinical implications. Monaldi Arch Chest Dis 2013; 80: 106-10.
6. Garcia MM, Lima PR, Correia LC. Prognostic value of endothelial function in patients with atherosclerosis: systematic review. Arq Bras Cardiol 2012; 99: 857-65.
7. Flammer AJ, Anderson T, Celermajer DS etal. The assessment of endothelial function: from research into clinical practice. Circulation 2012; 126: 753-67.
8. Villanova N, Moscatiello S, Ramilli S etal. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-80.
9. Zhao QH, Li X, Fu WG etal. Evaluation of brachial artery endothelial function in patients with nonalcoholic fatty liver disease by ultrasonography. J Med Imag 2006; 16: 824-6.
10. Senturk O, Kocaman O, Hulagu S etal. Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. Intern Med J 2008; 38: 183-9.
11. Wang T, Chen XH, Yin QF. The relation between endothelial function and insulin resist in nonalcoholic fatty liver disease. Med Info Med Surg 2009; 22: 1002-4.
12. Vlachopoulos C, Manesis E, Baou K etal. Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study. Am J Hypertens 2010; 23: 1183-9.
13. Thakur ML, Sharma S, Kumar A etal. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 2012; 223: 507-11.
14. Zhang DK, Chen M, Li ZY, Feng H, Liu Y. Evaluation of endothelial function in patients with nonalcoholic fatty liver disease by high resolution ultrasonography. Chin J Clinicians (Electronic Edition) 2012; 6: 589-92.
15. Wang J, Wei YL, Fan LL etal. Cardiovascular disease in patients with non-alcoholic fatty liver disease. J Clin Hepatol 2013; 16: 499-501.
16. Colak Y, Senates E, Yesil A etal. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine 2013; 43: 100-7.
17. Kucukazman M, Ata N, Yavuz B etal. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2013; 25: 147-51.
18. Zhang SJ, Su M, Meng Z, Li Y. Changes and significance of endothelial function and inflammatory Factor in patients with nonalcoholicfatty liver disease. J Chin Pract Diagn 2015; 29: 70-2.
19. Mohammadi A, Sedani HH, Ghasemi-Rad M. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc Health Risk Manag 2011; 7: 661-5.
20. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
21. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-23.
22. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573-7.
23. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009; 172: 137-59.
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
26. He WJ, Liu W, Kang LH. Detection of vascular diastolic function in young patients with fatty liver by ultrasound. Chinese Remedies & Clinics 2010; 10: 316-7.
27. Vladimirova-Kitova LG. Instrumental methods for evaluation of endothelial function. Folia Med (Plovdiv) 2006; 48: 5-15.
28. Stout M. Flow-mediated dilatation: a review of techniques and applications. Echocardiography 2009; 26: 832-41.
29. Jonk AM, Houben AJ, Schaper NC etal. Obesity is associated with impaired endothelial function in the postprandial state. Microvasc Res 2011; 82: 423-9.
30. Williams IL, Chowienczyk PJ, Wheatcroft SB etal. Endothelial function and weight loss in obese humans. Obes Surg 2005; 15: 1055-60.
31. Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010; 16: 1941-51.
32. Coulon S, Francque S, Colle I etal. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine 2012; 59: 442-9.
33. Soardo G, Donnini D, Domenis L etal. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord 2011; 9: 397-401.
34. Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 2008; 19: 371-9.
35. Mohammadi A, Ghasemi-rad M, Zahedi H, Toldi G, Alinia T. Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease. Med Ultrason 2011; 13: 200-6.